Docstoc

PROPOSAL

Document Sample
PROPOSAL Powered By Docstoc
					PROPOSAL FOR THE ESTABLISHMENT OF AN
INTRAVENOUS SOLUTION MANUFACTURING
FACILITY BY LVPS, Ltd.




Communications should be directed to Marketing Consultants at:


Nerve Access, Inc.
8534 Thomas Charles Ln
Hickory Hills (Chicago area), Illinois 60457
U S A
Telephone: 312 – 731 – 4949
           708 – 393 – 6383

E-mail: contact@nerveaccess.com
        ymaksoud@gmail.com
                                         EXECUTIVE SUMMARY

Project Definition: Establish an IV Solution Manufacturing Facility in the United
States to produce IV Solutions of various types and kinds for domestic use and
export to world markets, particularly where the heal th care market is growing
because of improved health care.

Product Description: A state-of-the-art medical manufacturing facility to produce
IV solutions for parenteral requirements and other solution needs. The basic raw
materials needed are water, med ical grade plastic resins, a few fine chemicals and
some common packaging materials. The product is packaged -ready-to-use in a
convenient sterile form. The product is a one -time-use “consumable” product that
meets the critical requirements demanded of IV products and in keeping with
today‟s health care standards. The product is not environmental threatening, and
“PRODUCT OBSOLESCENCE” is not a notable concern.

Product/Markets: The world markets continue to grow with an ever increasing
population and the c ontinuum of up -scaling of health care. Also new markets are
emerging in the home-care field and other alternative health care markets. For
example, a unique market exists in the U.S. The total market in the U.S. is in excess
of one billion units per year and is growing. Also, third world and emerging
nations that are building better and higher quality health care institutions and other
health care infrastructures present market opportunities. World markets are
growing at a faster pace because of the up -grading of health care in areas that was
once deemed to be dormant. Also, the newer developments in antibiotics and other
medicinals favor the intravenous (parenteral) method of use and application...and
current research indicates this will be the preferred administration form in the
future.

Multi-National Markets: All world markets are growing because of population
growth and citizen demands being placed on governments to up -grade their health
care.

Government Involvement: New pressures are being applied in the most countries to
curtail health care costs...these activities will enhance this project because this
business can effectively compete with existing companies in the field because of
state-of-the-art manufacturing techniques, production efficiencies and the
availability of competitive labor costs.

Profitability: The project will be profitable from start -up-forward and will have a
continuum of growth in volume in the foreseeable future. Pay -back of the initial
investment will be comparative short -term and it has the all the “earmarks” of an
attractive investment.

The project is a venture in a unique business arena --the health care field which is
deemed to be a recession resistant business and grows regardless of the state -of-
affairs of the economy. . .and harvests interesting profits.




Nerve Access, Inc.: Quality Research and Manufacture of Pharmaceuticals and Medical Products
8534 Thomas Charles Ln Suite A, Hickory Hills, IL 60457 – USA      Tel: 708 – 393 – 6383  Fax: 708 – 496 – 6466
Website: www.nerveaccess.com                                       Email: contact@nerveaccess.com
I.     WHAT ARE LARGE VOLUME PARENTERALS ?

Large volume parenterals (LVPs), also known as Intravenous “ I.V.”
S o l u t i o n s a r e a s e p t i c a l l y f i l l e d , t e r m i n a l l y s t e r i l i z e d , p yr o g e n - f r e e :

        A . L o w c o n c e n t r a t e s o l u t i o n s o f c a r b o h yd r a t e s a n d e l e c t r o l yt e s ,
            100 to 1000 millimeters in volume, which are intended for
            intravenous administration. They are intended to be administered
            per se, or in partially filled containers w hich are designed to
            accommodate other medications, and are administered with the
            aid of an administration set; and

        B. Water or solutions of low concentration, 1,000 millimeters in
           volume, which are intended fo r topical or medical/surgical
           non-patient use. They are packaged in containers which allow
           the contents to be poured out.


II. HISTORY OF COMMERCIAL LVPs .

        Large volume parenterals have been generally available in
        commerce since the 1940s. They are manufactured in relative
        few locations in the world and they are then transported to the
        point of use. Transportation is the major cost of LVPs.
        Few countries have the capacity to make quality LVPs.


III. PREAMBLE.

        LVPS,Ltd. is a corporation organized under the laws of the
        S t a t e o f I l l i n o i s , U S A ( S e e a c c o m p a n yi n g m a t e r i a l s . )

        LVS,Ltd. has the technology which permits large volume
        parenterals to be produced in the state -of-the-art plastic
        c o n t a i n e r , a t U n i t e d S t a t e s P h a r m a c o p o e i a ( “ U S P ” ) q u a l i t y,
        and meeting US Food and Drug Administration standards. The
        technology is embodied in the LVPS Micro-Facility ( a trade
        mark name for an intraven ous solution manufacturing
        f a c i l i t y ) a n d i s s h o w n i n t h e a p p e n d i x o f t h e a c c o m p a n yi n g
        m a t e r i a l s s c h e m a t i c a l l y.

      LVPS,Ltd. designs for each client and builds the Intravenous
      Solution Manufacturing Facility which produces LVPs fro m
      local water sources, fills the plastic container and autoclaves
      the finished product, ready for quality assurance testing and
      storage.

         LVPS, Ltd. provides the Intravenous Solution Manufacturing
Nerve Access, Inc.: Quality Research and Manufacture of Pharmaceuticals and Medical Products
8534 Thomas Charles Ln Suite A, Hickory Hills, IL 60457 – USA      Tel: 708 – 393 – 6383  Fax: 708 – 496 – 6466
Website: www.nerveaccess.com                                       Email: contact@nerveaccess.com
        MicroFacility for purchase, trains the client‟s personnel, provides
        pharmaceutical grade chemicals and plastics (when not available
        l o c a l l y) a n d v a l i d a t e s t h e i n - p r o c e s s c o n t r o l s o f t h e L V P S , L t d .
        Intravenous Solution Manufacturing MicroFacility at the
        purchaser‟s site and can provide a continuous quality assurance
        program so the products produced are according to US -FDA and US-
        CGMPs standards for the Life of the LVPS, Ltd. Intravenous
        Solution Manufacturing Mic roFacility.

IV.      THE PROPOSAL.

        1. Survey the location regarding construction of a facility or the
           utilization of an existing facility and its power, water and
           disposal services to receive an LVPS,Ltd. Intravenous Solution
           Manufacturing MicroFacility;

        2. Construct a 4 M LVPS,Ltd. Intravenous Solution Manufacturing
           MicroFacility* with an annual capacity to produce 4 million plastic
           containers of LVPs or a 8M LVPS,Ltd. Intravenous Solution
           Manufacturing MicroFacility* with an annual capacity to produce
           8 million plastic containers of LVPs in various sizes. The purchase
           price includes molds/Dies for two sizes: 250 and 500 millimeters
           ( o p t i o n a l l y, a 1 0 0 m l a n d u p t o 2 0 0 0 m l m o l d s c a n b e p r o v i d e d ) ; [ E i t h e r
           „ F o r m - F i l l - S e a l ‟ o r „ B l o w - F i l l - S e a l ‟ t yp e o f p a c k a g i n g a n d t e c h n o l o g y
           c a n b e p r o v i d e d w i t h t h e M i c r o F a c i l i t y. ]

        3. Validate the LVPS, Ltd. Intravenous Solution Manufacturing
           MicroFacility at the construction site, so that they are in accord
           US-FDA and US-CGMPs standards;

        4 . T r a i n t w o t e a m s o f t h r e e p e r s o n n e l f o r t h e 4 M f a c i l i t y* o r f o u r
            t e a m s o f t h r e e p e r s o n n e l f o r t h e 6 M f a c i l i t y* a t t h e c o n s t r u c t i o n
            site and certify their competence to operate the LVPS, Ltd.
            Intravenous Solution Manufacturing MicroFacility.

        5. Transships the LVPS, Ltd. Intravenous Solution Manufacturing
           MicroFacility to the purchaser‟s port of entry --- all duties,
           permits and licensees to be obtained by the purchaser ; [U.S.Exempt]

       6. Direct the reassemble of the LVPS ,Ltd. Intravenous Solution
          Manufacturing MicroFacility under the supervision of
          LVPS, Ltd. on location within the facilities of the purchaser;
          the cost of the local labor is the expense of the purchaser;

       7. Revalidate the in-process controls and operation of the
          LVPS, Ltd. Intravenous Solution Manufacturing MicroFacility
          t o t h e s t a n d a r d s o f t h e U S - F D A a n d U S - C G M P s e m p l o yi n g t h e
          owner/operator‟s personnel, previously certified by LVPS, Ltd.
Nerve Access, Inc.: Quality Research and Manufacture of Pharmaceuticals and Medical Products
8534 Thomas Charles Ln Suite A, Hickory Hills, IL 60457 – USA      Tel: 708 – 393 – 6383  Fax: 708 – 496 – 6466
Website: www.nerveaccess.com                                       Email: contact@nerveaccess.com
ALL OF THE ABOVE will be performed in consideration of an estimated sum
of US $6.5 million for the 6M LVPS, Ltd. Intravenous Solution
Manufacturing MicroFacility* and US $12.5 million for the 10M LVPS, Ltd.
Intravenous Solution Manufactur ing MicroFacility*, terms to be arranged
and the completion date to be approximately 12 Months from agreement
between contracting parties. If required, building, operating steam, power
source, and site improvements are added costs to this proposal.

    T w o ( 2 ) , e i g h t ( 8 ) H o u r S h i f t s - s i x ( 6 ) d a ys a w e e k - 3 0 6 d a ys a ye a r - w i t h
     ample allowances for „Down -Time‟ and other exigencies.

V.       ON-GOING SUPPORT OF THE LVPS, Ltd. MICRO -FACILITY.

        1. Maintain a technical Support Relationship for a required pe riod;
           perform batch quality assurance testing and provide maintenance
           for a fee per LVP container produced.

         2. Provide replacement parts within 48 hours of notice to its
            offices in Chicago, IL, U.S.A., to an international airpor t and
            airline office of the owner/operator‟s choosing, and at a cost
            posted on LVPS, Ltd. price list.

         3. Re-certify and train subsequent personnel at an established fee.

         4 . S p e c i f y a n d p r o v i d e ( w h e n n o t a v a i l a b l e l o c a l l y) q u a l i t y r a w
             materials and supplies which meet US -FDA standards.

         5. Support the owner/operator in terms of this proposal and
            technicalogically to manufacture quality products.




Nerve Access, Inc.: Quality Research and Manufacture of Pharmaceuticals and Medical Products
8534 Thomas Charles Ln Suite A, Hickory Hills, IL 60457 – USA      Tel: 708 – 393 – 6383  Fax: 708 – 496 – 6466
Website: www.nerveaccess.com                                       Email: contact@nerveaccess.com
LVPS, Ltd.
BACKGROUND

LVPS, Ltd. is a technology-transfer corporation, located in Chicago, Illinois, U.S.A. Its principals are

published individuals trained in the science and practice of manufacturing pharmacy.

      Manufacturing pharmacy deals with the production of dosage-form of medications by reliable high-

volume production methods. The principal dosage-form of interest to the principals throughout their careers

has been parenteral products, both small and large volume types, along with the medical devices to

administer them.

      The principals of LVPS, Ltd. sought and discovered a method of producing LVPS 1) without the

need to invest a large amount of capital, 2) which could serve a regional need for LVP products, 3) which

avoids the significant costs of transporting products (basically sterile water), and 4) having a higher order of

sterile reliability than required by current standards. The method relies upon experience and equipment

drawn from both the U.S.A. and Europe.

      LVPS, Ltd. believes a reliable quality product of four components: 1) documentation of the method

of manufacture, 2) known reliability equipment, 3) properly trained personnel and 4) an established

quality of raw materials. The experience of many countries has been that the arrival of equipment alone

does not produce a quality product, if production commences at all. LVPS, Ltd. has set out the past several

years to develop commercial and scientific relationships to achieve its goals. A network of representatives

now present its capabilities in technology transfer to governments, individuals, corporations and

engineering/construction companies. LVPS, Ltd. intends to provide to every medically developing country

an ingenious capacity to produce its own basic components for quality medical care, as well as goods for

export of high-value pharmaceutical type products.
LVPS, Ltd. and Associates

LVPS, Ltd. is a consortium of sizable and diverse
dimensions.

It is an alliance of participating Busin esses together with a
coalition of individuals with specialized and specific
knowledge and experience.
The above referenced entities will be ascribed and identified
in the following paragraphs.

LVPS, Ltd. is the contractor, coordinator, and expediter of
all facets of the construction and implementation of the
Micro-Manufacturing Facility for Intravenous Solutions for
delivery to the purchaser.

The ‘Scope of Work’ of participants follow:

LVPS, Ltd. and its principals are the creators of the basic
design and technology transfer vehicle meeting all
Governments Healthcare Authorities Standards and
Criteria.

Dynamic Engineering, Inc., { Web Site: dynamicengineer.com
} located in Sturgis, Michigan - (Close proximity to
Chicago), is the company that performs the finite
engineering, inspect the proposed location for the project,
evaluate the viability of each location, question assumptions
and compare with similar successful installations. Develop
preliminary project programming installation, identification
of the project design team, construction phasing, plan to
maintain production continuity, space/staging needs,
infrastructure availability (i.e. Utilities, Power, Quality of
Air, etc.) Conduct all the above activities in concert with
LVPS, Ltd., PharmTech, Inc., W. Soule Company, CA, Inc.,
and others.

PharmTech, Inc. { Web Site: www.pharmtechinc.com } located
in a suburb of Chicago is the Company that performs the
required Validation, PSM Planning and Commiss ioning




Nerve Access, Inc.: Quality Research and Manufacture of Pharmaceuticals and Medical Products
8534 Thomas Charles Ln Suite A, Hickory Hills, IL 60457 – USA      Tel: 708 – 393 – 6383  Fax: 708 – 496 – 6466
Website: www.nerveaccess.com                                       Email: contact@nerveaccess.com
Support. PharmTech supports LVPS, Ltd. with technical
writers and validation specialists. They also render support
in the development of critical documents necessary to assure
the highest quality products associated with the following
document categories; 1) Quality Management Policy
Documents; 2) Critical System Standard Operating
Procedures; 3) Preventive Maintenance and Calibration
Forms; 4) Production Standard Operating Procedures; 5)
Production Batch Documentation; 6)Laboratory Equipment
Procedures. In addition, they will assist in Preparing Plans
and Schedules, Manage Technical Resources, Prepare SOPs
Per cGMPs, Evaluate Each Systems Operating Requirements,
Write Validation Protocols For Critical Systems, Execute
Validation Tests and Develop Protocols for ranges,
tolerances, frequency, etc. Conduct all the above activities
in concert with LVPS, Ltd., Dynamic Engineering Inc.,
W.Soule Co., CA, Inc. & others

W. Soule Company { Web Site: www.wsoule.com } is also
located in Michigan.(near Dynamic Engineering, Inc.) is the
company that performs the assemblage, fabrication and
participates in the training of personnel as well as
preparing the facility for shipment to the purchaser with
subsequent supervision of installation at the purchaser’s
site within the building erected and readied to receive the
facility. Conduct all the above activities in concert with
LVPS, Ltd., PharmTech, Inc., Dynamic Engineering, Inc.,
CA, Inc. and others.

CA, Inc. (NYSE: CA) provides software solutions that
enable customers to more effectively govern, manage and
secure their increasingly complex information technology
environments. By unifying and simplifying IT management,
CA’s Enterprise IT Management vision empowers
organizations to optimize business performance and sustain
competitive advantage. Founded in 1976, CA serves
customers in more than 140 countries.

George Ichichiata, Consultant - a Nisei-Japanese and
notable Chicago Engineer/Water Chemist, presently




Nerve Access, Inc.: Quality Research and Manufacture of Pharmaceuticals and Medical Products
8534 Thomas Charles Ln Suite A, Hickory Hills, IL 60457 – USA      Tel: 708 – 393 – 6383  Fax: 708 – 496 – 6466
Website: www.nerveaccess.com                                       Email: contact@nerveaccess.com
associated with the Wesley-Jessen Corporation (Recently
acquired by a European Firm) a premier supplier of eye care
needs to ophthalmic facilities in the world.

Corporate Staff Engineers and Technicians from the
principal suppliers of required Equipment i.e. Steris, Inc.,
AMSCO and Finn-Aqua, etc.

University of Illinois, University of Chicago, Northwestern
University and the Midwest College of Pharmacy . All are
Institutions of Education and higher learning located in the
Chicago area and are providers of academicians for
personnel training and are sources of consultation.

Plus a myriad of local providers and suppliers of minor,
but, essential
needs together with logistical support facilities - - - i.e.
transportation
and shipping firms along with the necessary Insurance
providers and other administrative functions.

Note: Chicago is the site of the ‘first’ preparation of
commercial Medical Intravenous Solutions and ‘still -to-this-
day’ maintains world leadership in the industry with
leading companies in the industry headquartered in Chicago
along with some production facilities. Hence, the ‘pool’ of
talent and experience related to this industry is virtually
limitless and available to LVPS, Ltd. and its associates.

You are welcome to visit any of the above entities. Kindly
let me know your agenda and I will make the arrangement(s)
for you.




Nerve Access, Inc.: Quality Research and Manufacture of Pharmaceuticals and Medical Products
8534 Thomas Charles Ln Suite A, Hickory Hills, IL 60457 – USA      Tel: 708 – 393 – 6383  Fax: 708 – 496 – 6466
Website: www.nerveaccess.com                                       Email: contact@nerveaccess.com
PRODUCTION COST ANALYSIS

JORDAN - PROJECT
(Example for establishment of a project in Jordan)*

COST OF LABOR per Unit of Production

Salaries and wages per Unit of
Production..……………………… US$0.020

Employer Contributions-
(Benefits???)………………………………                                                       0.005

Total Cost of
Labor………………………………………………………..                                                                         0.025



PRODUCTION COST per Unit of Production

Utilities (Water, Electricity, Gas,
etc.)………………………………                0.010

Raw Materials (Fine Chemicals,
etc)………………………………….                                                0.060

Supplies (Plastic Materials, Labeling and
Packaging)……………         0.140

Liability
Insurance*………………………………………………………
0.015

Service Policy Agreement (Q.A.)[Based on U.S.
Operations]**     0.029

Total Costs per Unit of
Production…………………………………….                                                          0.274




Nerve Access, Inc.: Quality Research and Manufacture of Pharmaceuticals and Medical Products
8534 Thomas Charles Ln Suite A, Hickory Hills, IL 60457 – USA      Tel: 708 – 393 – 6383  Fax: 708 – 496 – 6466
Website: www.nerveaccess.com                                       Email: contact@nerveaccess.com
Building Costs to house manufacturing
operations………………….        0.015

Total Costs of Labor and Production per Unit of
Output………..      0.294

**Optional.

 The example cited above is for the establishment of a project in
    the country of Jordan. In the United States the costs of
    production will vary, depending on the site or location of the
    manufacturing facility. Example: In Chicago, Illinois, the co st
    of production at this point in time is an average of fifty -three
    (US$0.53) cents. In order to arrive at a specific cost for any
    given location, we must have some specific ‘inputs’ relating to
    costs in that area.




Nerve Access, Inc.: Quality Research and Manufacture of Pharmaceuticals and Medical Products
8534 Thomas Charles Ln Suite A, Hickory Hills, IL 60457 – USA      Tel: 708 – 393 – 6383  Fax: 708 – 496 – 6466
Website: www.nerveaccess.com                                       Email: contact@nerveaccess.com
PERSONNEL REQUIREMENTS FOR A 4M FACILITY 2 SHIFTS PER DAY

FUNCTIONS                     NUMBER              TOTAL/DAY                 ADDITIONAL              ANNUAL
                              REQUIRED           REQUIREMENT               SPONSIBILITIES          EARNINGS

OVERHEAD FUNCTIONS

Managing Director*                   1                     1                   + Personnel
Operations Manager*                  1                      1                  + Purch & Stores
Bookkeeper                           1                      1                  + A/Rec & Acct.
Q & A Manager                        1                      1                  + Stores
Customer Service Manager             1                      1                  + Inv. Control
                                                          -----                                     ----------------
 SUB-TOTAL OVERHEAD FUNCTIONS                               5                                    US$


DIRECT FUNCTION


Pharmacists                    1/Shift                     0*
Engineer/Mechanic/Maint         1/Day                      1
Tech, Production/Sterilization 2/Shift                     4
Packaging                      2/Shift                     4
Warehouse Man                   2/Day                      2
Chauffeur/Truck Driver         1/Day                       1
                                                         -------                                     -----------------
SUB-TOTAL DIRECT COST FUNCTION                            12                                      US$


     TOTAL PERSONNEL REQUIRED                             17                         Subtotal     US$


PROJECTED BONUS PAY (etc.)                                 UP TO %          US$
                                                PROJECTED TOTAL ANNUAL COST US$


TOTAL UNIT COST PER UNIT ( Total Labor Cost ) US$           = US$                                       /Unit
                        ( Annual Production ) _,000,000 Units


* Note: One Pharmacist is deemed the Managing Director and One Pharmacist is deemed to be the
        Operations Manager of the manufacturing facility.




Nerve Access, Inc.: Quality Research and Manufacture of Pharmaceuticals and Medical Products
8534 Thomas Charles Ln Suite A, Hickory Hills, IL 60457 – USA      Tel: 708 – 393 – 6383  Fax: 708 – 496 – 6466
Website: www.nerveaccess.com                                       Email: contact@nerveaccess.com
DEMOGRAPHIC PROFILE

      The population of the United is estimated to be 300,000,000+/ -

and the number of                   hospitals being 5000 +/- with 1,000,000+/- Beds.


       The United States has four(4) basic categories - The Federal

Government owns and operates 285 Hospitals with a 62,000 bed count.

The States and Local Governments owns and operates 1,260 Hospitals

with a 148,000 bed count. Non-Profit Hospitals (Normally Religious

Organized and Affiliated Hospitals.) operate 3000 Hospitals with a

bed count of 591,000 beds and investor owned hospitals number 797

with a bed count of 115,000. This montage of institutions repre sent a

plethora of hospitals well under 200 beds, however, there are a few,

which are deemed to be „larger hospitals‟. These large institutions are

usually University or Government Hospitals and Institutions.


   The United States healthcare level /status uses on the average
about

four(4) units of I V solutions for every man, woman and child which

represents more than One Billion (1,200,000,000) units..


I.V. solutions are used in a number of places other than hospitals, i.e.

Clinics, Homes, Health Centers, etc. For example, the Home Health

Care market in the United States is at a high level, mature and a

sophisticated market is currently increasing at the rate of 18% per

year.



Nerve Access, Inc.: Quality Research and Manufacture of Pharmaceuticals and Medical Products
8534 Thomas Charles Ln Suite A, Hickory Hills, IL 60457 – USA      Tel: 708 – 393 – 6383  Fax: 708 – 496 – 6466
Website: www.nerveaccess.com                                       Email: contact@nerveaccess.com
     The number of LVPs that are utilized per hospita l can be

estimated, based upon the statistical information available.

The consumption of LVPs in a General Hospital is approximately 2.5+

LVPs per person in United States on a per occupied hospital bed basis,

LVPs are consumed at the rate of 3.5 units per occupied bed per day in

tertiary care hospitals . Consequently, the total annual market is
deemed

to be a considerable amount in number of units.




Nerve Access, Inc.: Quality Research and Manufacture of Pharmaceuticals and Medical Products
8534 Thomas Charles Ln Suite A, Hickory Hills, IL 60457 – USA      Tel: 708 – 393 – 6383  Fax: 708 – 496 – 6466
Website: www.nerveaccess.com                                       Email: contact@nerveaccess.com
ENVIRONMENTAL ASPECTS OF LVPS Ltd. MANUFACTURING

     The manufacturing of Intravenous Solutions is a clean, non -
polluting Industry. All products are intended for medical/surgical
applications and human consumption and usage. In addition, all by -
products are deemed not to be pollutants and do not encroa ch upon the
environment or area in which the plant is placed.

    The manufacturing facility complies with all the United States
Government Environmental Protection Agency parameters and all
known regulations and rules of other countries.

WASTE DISPOSAL

      The production of waste is an output which must be accounted
for. The accompanying Flow Chart details the kind of waste which i s
produced by the facility. The quantify of waste is discussed below by
type.

         Solid Waste

         The solid waste from the LVP, Ltd., Micro -Facility is minimal.
         The Industry is “clean” in this regard. NO more than scrap
         from the in-coming cartons or raw materials is accumulated out
         of the production process. A great preponderance of scrap is
         packaging materials and is bio-degradable. The remainder may
         be buried or incinerated.

         Liquid Waste

          The waste water is no more obnoxious than sanitary wastes.
          The inclusion of cooling water and rinse water from the
          equipment results in waste less concentrated than sanitary
          waste. The annual volume of liquid is expected to be
          less than 10,250 metric tons.

      The low concen tration of sugar and salt in the LVPs results
      in low concentration of these chemicals in the waste. The
      sugar and salt are biological products, not different from
      human waste, and lack any serious detriment to the
      environment. Nothing is environmental threating, The
      production of LVPs is an “ultra -clean” medical manufacturing
Industry



Nerve Access, Inc.: Quality Research and Manufacture of Pharmaceuticals and Medical Products
8534 Thomas Charles Ln Suite A, Hickory Hills, IL 60457 – USA      Tel: 708 – 393 – 6383  Fax: 708 – 496 – 6466
Website: www.nerveaccess.com                                       Email: contact@nerveaccess.com
.




PRODUCTION COST ANALYSIS
                                      [4,000,000 - 500ml Units per Year]

LABOR                                                                                    COST per Year

Operations Manager
Quality Technicians
Pharmacists
Engineers
Production Technicians
Sterilization Technicians
Machine Operators
Warehousemen
                                                                                          _____________
Total Labor Costs



UTILITIES

Total Utilities Costs                                                                     -----------------



SPACE [ AREA ]                                                            SQUARE FEET(15,000)



Total Space Costs                                                                          -----------------




Nerve Access, Inc.: Quality Research and Manufacture of Pharmaceuticals and Medical Products
8534 Thomas Charles Ln Suite A, Hickory Hills, IL 60457 – USA      Tel: 708 – 393 – 6383  Fax: 708 – 496 – 6466
Website: www.nerveaccess.com                                       Email: contact@nerveaccess.com
FLOW CHART FOR PREPARATION OF INTRAVENOUS SOLUTIONS UTILIZING LVPS, Ltd. MANUFACTURING ‘Micro-Facility’
   _________________________________________________________________
           Primary           Primary                                    Pharm’cal          Medical       Packaging
INPUTS : Energy             Water                                       Grade              Grade         Materials
>>>>>> Source               Source                                      Chemicals          Plastic             l
               l               V                                            V                V                 V
               l           Filtration                                   ----Quarantined Raw Materials Storage ---
               l                 l                                           V               V                 V
               l               V              Testing-----------------Quality Assurance Testing and Release-
               l                 l                                           V               V                V
               l                 l                                          -----Production Goods Inventory-----
               l               V                                             l                1                1
               1          Deionizer                       Sal t              1                1                1
               1                 1                       Water               l                1                1
               1                 1-----------Testing        1                l                1                l
               1                 1                           1               1                1                1
               1                 1                           1               1                1                l
              V                V                             l               l                l                l          ----
          Primary---- Prepared                               l                l               1                 1
          Steam .         Water                             l                 l               l                 l
    c . Boiler . for                                        l                I                l                l
    o.         l       . Manufacturing----------Sanitary                      l                l                l
    n .      sl        .        l                           Waste            l                 l                 l
    d .      tl        .         l                           l                l                 1                l
    e.       el        .         l                           l               l                  l                l
    n .     al          . Multiple-------------------Warm                    l                  l                1
    s .     ml         .     Effect                       Clear               l                  l                l
    a.        1`------------ Still                        Water               l                 l                 l
    t .       l                 l                            l                l                  l                l
    e .       l                 l------------Testing          1               l                  l                l
      ----Pure Steam           V                             1               1                   l                 l
         Generator            Stock                       Clear               l                 l                  1
              l              Tank-----------------------Water                 l                  l                  l
            pl                  l                              l               l                 l                  l
            ul                  l-------------Testing         1                l                 l                 l
            rl                 V                              1                l                 l                  1
            el               Process---------------------------------- V                         l                  l
              l              Tank-----------------------Sanitary                                  l                 l
            sl                  l                         Waste                                   l                 l
            tl                 V -------------Testing Sugar                                       l                  l
            el              Form-Fill-Seal               & Salts                                   l                 l
            al               Blow-Fill-Seal--------------- l…………………………… ..V                                          l
            ml               Extruding                         1                                                      l
              V------------- Machine---------------------- 1------------Plastic                                       l
              l                   l                            V                Flashing                              1
              1                   V                        Warm                    l                                  l
              V-------------Air-Steam                      Clear                    l                                 1
                                  l                              l                  l                                 1
                                  l-------------Testing          l                  l                                 1
                                  l                              l                  1                                  l
                             Autoclave------------------- Water                      l                                 l
                                  l------------- Testing          l                  l                                 1
                                  l                               l                  l                                  l
                                  1                               1                  1                                 1
                                 V                                l                   l                                 1
                            Packaging……………………………………………………………………. …V
                               An d                               l                   l
                            Labeling ----------------------------------------Paper
                                 l                                 l               Stock
                                 l--------------Testing             l                   l
                               V                                    l                   l
                            Quarantine 21 Days                      l                   l
                             Finished                               I                   l
                             Goods                                  l                   l
                               V                                    l                    l
                             Finished                               l                    1
                             Goods                                 V                    V
                             for                                Liquid              Solid
OUTPUTS                      Shipping                            --------Wastes-------
>>>>>>>>                      _______                          ________________



Nerve Access, Inc.: Quality Research and Manufacture of Pharmaceuticals and Medical Products
8534 Thomas Charles Ln Suite A, Hickory Hills, IL 60457 – USA      Tel: 708 – 393 – 6383  Fax: 708 – 496 – 6466
Website: www.nerveaccess.com                                       Email: contact@nerveaccess.com
DETAILED EQUIPMENT LIST AND OTHER MAJOR PRODUCT
TASKS FOR LVPS, Ltd. SOLUTION MICRO-FACILITY

1.    -     HARDWARE

QTY                                           ITEM


1           Form-Fill Seal Machine with one set of Dies included
1           Conveyor Stainless Steel Assembly with Automatic Control
1           with Airlock for protection of Aseptic Production Area
1           Autoclave Model AC121225D Air-Steam Finn-Aqua Steris
2           Side Wall for Autoclave containment No. 4 Finish
9           Cart Model CRT 121212
108         Shelves, 12/Cart, SHC-1212
2           Transfer Trolley for Autoclave Finn-Aqua Steris
7           Parking Stands PSC-121212
1           Two-Piece Delivery
1           Multi-Effect Still Model 300-H-5 Finn-Aqua Steris
1           Cabinet for containment of still
1           Electro-Polishing to meet accepted regulatory cGMPs
1           Feed water Booster Pump System
1           After-Cooler Model FAAC-300
1           CALCO Water Treatment Unit w/Capacity 15 GMP
1           Pure Steam Generator Model 500-H-1 Finn-Aqua Steris
1         Cabinet For Containment of Steam Generator
1         Regulator, Pressure, Pure Steam
1         Conductivity Recorder, Pure Steam to meet regulatory cGMPs
1         Feed-Water Conductivity Recorder
1         By-Pass For Flow Valves
1         Electro-Polishing to meet accepted regulatory cGMPs
1         Steam Extractor Stainless Steel Hood
1         Holding Tank Stainless Steel with #8 polish surface
1         Tank Venting System
1         Mixing Tank Stainless Steel #8 Polish Surface
1         Agitator for aseptic mixing of product
1         Materials handling Equipment
1         Labeling and Packaging Equipment for flex units and carto ns
1         Support Curb, Penetrators
1         Shelving, Benches and Platforms
          Freight-In for all the above Components




Nerve Access, Inc.: Quality Research and Manufacture of Pharmaceuticals and Medical Products
8534 Thomas Charles Ln Suite A, Hickory Hills, IL 60457 – USA      Tel: 708 – 393 – 6383  Fax: 708 – 496 – 6466
Website: www.nerveaccess.com                                       Email: contact@nerveaccess.com
2. - HEATING, VENTILATION & AIR CONDITIONING

  The climate and microbiological control of the environment
conditioning system has been es timated based on typical local
conditions, with a controlled working temperature of
approximately 21 degrees C and a controlled humi dity of
approximately 40%, to provide class 100 in the filling area and not
less than class 10,000 in adjacent areas.


QTY                          ITEM
1   HVAC System for modules
1   HEPA Class 100 over filling station


3.     MECHANICAL & ELECTRICAL

QTY                            ITEM
2   Filter Systems, Pre and final to meet regulatory cGMPs
2   Pumps Aseptic Sanitary Stainless Steel
1   Drains and Sewers applicable to controlled environment
1   Piping, Fittings and Valves meets regulatory and ASME Code
    Stainless Steel & pneumatically operated
1   Conduit, Wiring, Outlets and Motors and Starters to meet
    Electrical and Building Codes
1   Sinks, hand-dryers w/vents, eye-washers and safety showers
1   Utility piping and installation meets regulator y & ASME
    Codes
1   Safety Reflectors Stainless Steel


4.     MODULES

QTY.                              ITEM
4    Skids, Steel reinforced
4    Transport Carriages
4     Frame, Steel and Plate
4     Interior Surface Preparation
4     Exterior Surface, Aluminum
80    Panels meeting regulatory cGMPs
100   Ceiling Finish meeting regulatory cGMPs
2     Air Lock Entry for protection of controlled environment
1     Ceiling, Insulated, Panel and Frame
1     Coves sanitary meeting regulatory cGMPs
3     Man-Doors, Windows, Frames and Hardware
1     Utility Room Double Door
4     Interior Doors Gasketed to protect controlled environment

Nerve Access, Inc.: Quality Research and Manufacture of Pharmaceuticals and Medical Products
8534 Thomas Charles Ln Suite A, Hickory Hills, IL 60457 – USA      Tel: 708 – 393 – 6383  Fax: 708 – 496 – 6466
Website: www.nerveaccess.com                                       Email: contact@nerveaccess.com
6          Windows Exterior Gasketed to protect controlled
           environment
2           Autoclave Penetrations to protect controlled environment
10          Exterior Windows double-glazed for controlled environment
1           Fluorescent Lighting
1           GFI Receptacles
1            Instrument Loops



5.    QUALITY ASSURANCE LABORATORY

QTY.                     ITEM
1    Complete Quality Assurance Testing Laboratory



6.       COMPUTER / PROGRAMS & COMMUNICATION EQUIPMENT
1         Main Computer
3         Terminals
1         Software System
4         Printers
1         Facsimile for International and Domestic Communication
4         Modems
4         Furniture to accommodate above equipment




7.    VALIDATION, CERTIFICATION & GOVERNMENT
     APPROVALS

Supplies for full production runs and trials during Validation and
Training Periods.

Preparation of documents for Validation and Certification.

Product Assay, both process testing and analysis of product.

Production Runs, full production and qualification.

Validation Procedure & Certification & Government Affairs.



8.     PERSONNEL TRAINING

Housing, Meals and Maintenance of Personnel while in U.S.A.
Training Materials and Manual for operation of Facility.

Nerve Access, Inc.: Quality Research and Manufacture of Pharmaceuticals and Medical Products
8534 Thomas Charles Ln Suite A, Hickory Hills, IL 60457 – USA      Tel: 708 – 393 – 6383  Fax: 708 – 496 – 6466
Website: www.nerveaccess.com                                       Email: contact@nerveaccess.com
9.      ENGINEERING
         Design
         Technology Transfer
         Shop Drawings
         Equipment Manuals
         Capacity Requirements
         Site Specification
         Field Supervision
         Field Office
         Architectural Design and Specifications for Building/Land
         Transportation, Housing, Meals and maintenance


10.      ADMINISTRATION AND LEGAL EXPENSES
         Sales Agreement
         Financial Agreement
         Regulatory Affairs
         Insurance, Taxes and Export Declarations



11.      TRANSPORTATION OF MODULES
         Ocean Freight Fees (if, Applicable)
         Packaging, Crating and Disassembly
         Housing and Engineering activities



12.      THE FOLLOWING ARE NOT INCLUDED:

           Primary and/or Auxiliary Steam Requirements
           Primary and Auxiliary Electrical Requirements
           Water and Water Storage if Required
           Building and Warehousing Facility
           Local Government Approvals, Duties and Taxes




Nerve Access, Inc.: Quality Research and Manufacture of Pharmaceuticals and Medical Products
8534 Thomas Charles Ln Suite A, Hickory Hills, IL 60457 – USA      Tel: 708 – 393 – 6383  Fax: 708 – 496 – 6466
Website: www.nerveaccess.com                                       Email: contact@nerveaccess.com
ELABORATION ON THE PRODUCT LINES OF THE
MANUFACTURING MICRO-FACILITY

The capability of the I.V. Micro-Manufacturing system to provide
the Owner/operator with a broad range of products, as noted in the
“Product Lines’ section of the Proposal, will be elaborated here. It
is our purpose here to provide greater detail to the discussion in
the LVPS, Ltd. Proposal.

SIMPLE LARGE VOLUME PARENTERIAL SOLUTIONS

The I.V. Micro-Facility has the capability to produce all possible
combinations of formulations of solutes, concentrations of solutes
and various volumes in plastic containers.

Examples of solutes: dextrose, fructose, sodium, chloride,
potassium chloride, sodium lactate, sodium acetate, calcium
chloride, potassium phosphate, sodium gluconate and sodium
bicarbonate.

Examples of volumes: 100ml, 150ml, 250ml, 1000ml, 2000ml

Examples of formulations and typical concentrations:

                  Dextrose in Water                      2.5, 5, 10, 20%

                  Sodium Chloride in Water                                0.22, 0.33, 0.45, 0.9%

                  Dextrose            2.5, 5, 10,20%                with Sodium Chloride
                                                                     0.22,0.33, 0.45, 0.9% in Water

                  Ringer Solution containing sodium, calcium and
                                             potassium chlorides 156mEq/L

                  Lactated Ringers Solution adding sodium lactate 28mEq/L

                  Dextrose in Lactated Ringers Solution

                 Multiple Electrolytes Solutions 48, 56, 148, 158mEql

                  Dextrose in Multiple Electrolytes (All combinations and
                                                            concentrations)
                  Sodium Lactate Solution 167mEq/L

                  Fructose in Water                            5, 10%

                  Dextrose and Fructose in Water (various concentrations)
                  Water for Injection
Nerve Access, Inc.: Quality Research and Manufacture of Pharmaceuticals and Medical Products
8534 Thomas Charles Ln Suite A, Hickory Hills, IL 60457 – USA      Tel: 708 – 393 – 6383  Fax: 708 – 496 – 6466
Website: www.nerveaccess.com                                       Email: contact@nerveaccess.com
     Typically a catalog of products from a major US producer has
as many as 80 products in th is category, differing in formulations
of solutes, concentrations of the solutes and volume of the bag. Of
these many infusion products, a hospital may use no more than 40
different products. As a consequence, sales of LVPs in the US
market are concentrated in 30 to 40 highly used products.

     These simple LVPs are intended to be the initial product line
for the owner/operator of an I.V. Micro -Manufacturing Facility. As
operating personnel gain experience with the facility and the
market for more sophisticated products has been determined, the
following product lines may be introduced.

LVPS INTO WHICH OTHER COMPONENTS AND MEDICATIONS
HAVE BEEN FORMULATED.

     1. The 150ml bag of dextrose 5% or sodium chloride 0.9%
solution may be used as the solven t for antibiotics, known to be
stable in solution. The use of the 150ml bag accounts for as much
as 40% of the US market in hospitals.

      2. The addition of drugs and other electrolytes is practical
to formulate cardioplegic solutions. The narrow market for th is
product is profitable where cardiovascular surgeons are practicing
and they demand the product.

      3. The need for large volumes of medical -grade water in
treating the burned patient is provided for by the I.V. Micro -
Manufacturing Facility, with and without medications in solution.
The capability to produce medical -grade water may be exploited to
meet these needs.

      4. Peritoneal dialysates are carbohydrate and electrolyte
solutions of specific formulations and in a 1000 or 2000ml bag.

           Dextrose 1.5% in Electrolyte Solution 146mEq/L
           Dextrose 1.5% in Electrolyte Solution 146mEq/L with
                                           Potassium Chloride 4mEq/L
           Dextrose 1.5% in Electrolyte Solution 137mEq/L
           Dextrose 1.5% in Electrolyte Solut ion 141mEq/L
           Dextrose 4.5% in Electrolyte Solution 146mEq/L with
                                           Potassium Chloride 4mWq/L
           Dextrose 4.5% in Electrolyte Solution 137mEq/L

           Dextrose 4.5% in Electrolyte Sol ution 141mEq/L




Nerve Access, Inc.: Quality Research and Manufacture of Pharmaceuticals and Medical Products
8534 Thomas Charles Ln Suite A, Hickory Hills, IL 60457 – USA      Tel: 708 – 393 – 6383  Fax: 708 – 496 – 6466
Website: www.nerveaccess.com                                       Email: contact@nerveaccess.com
     These products take advantage of the production capability of the I.V. Micro -Manufacturing
Facility and the need for these higher margin -of -profit products in dialyzing patients with failing
kidneys. Peritoneal dialysis is the preferred m ethod in many countries over hemodialysis.

     Hemodialsis concentrates of salts and carbohydrates may
also be produced by the I.V. Micro -Manufacturing Facility and filled in large containers. This
capability takes advantage of the availability of me dical-grade water. The product itself does not
need to meet the same sterility and pyrogen standards as LVPs.

     5. The production of patient-intended amino acid solutions
in hospital pharmacies in the US uses simple LVPs into which amino acids packaged in glas s
containers have been added by means of sterile transfer tubing. Amino acids are stable in solution
in plastic for the period of time during which the patient is infused.


SPECIAL COMPOUNDED PRODUCTS.

     1. Major innovators of pharmaceutical products may n ot have the capability nor the capacity
to produce parenteral products. The
regional I.V. Micro-Manufacturing Facility is in a position to exploit this need.

     2. During clinical studies of innovation drugs, the study of an oral dosage -form is common but
parenteral dosage-forms less common. This opportunity to provide LVP dosage -forms of a drug
under study may open up the opportunity to produce it subsequent to the completion of the clinical
studies.

    These two examples of markets develop out of local op portunity and the expertise of the
owner/operator technically if called upon to do so and if it is within its capability.

IN CONCLUSION, LVPS, Ltd. offers for sale on a ‘turnkey’ basis an I.V. Micro -Manufacturing
Facility which is US-FDA approvable. LVPS, Ltd. engages only in projects which meet all the
criteria of the Good Manufacturing Practices as established by US Law and regulation. Before
LVPS, Ltd. releases an I.V. Micro-Manufacturing Facility, the facility must comply with all
applicable regulatory factors.


Nerve Access, Inc.: Quality Research and Manufacture of Pharmaceuticals and Medical Products
8534 Thomas Charles Ln Suite A, Hickory Hills, IL 60457 – USA      Tel: 708 – 393 – 6383  Fax: 708 – 496 – 6466
Website: www.nerveaccess.com                                       Email: contact@nerveaccess.com
I N P U T S / O U T P U T S >>>>>>>>>>>>>>>>>>>>>>>>>>>>
For Rated Capacity                                                                                                4M Micro-Facility    8M Micro-Facility

1. Area in square met ers (Manufacturing Only)                              929                                                                1,858
   (Does not include Employee Areas, Warehouse Area, Offices & Utility Rm.)

2. Work Days per Year                                                                                                           306              306
       Output IV units per year                                                                                           4,000,000        8,000,000
       Output IV units per operating Day                                                                                     13,072           26,144
       Average size of IV unit in ml                                                                                            500              500

3. Packaging Machin e(Form-Fill-Methodology)                                                                                      1                1

4. Autoclave                                                                                                                      1                 1

5. Still                                                                                                                          1                    1

6. Pure Steam Generator                                                                                                           1                    1

7. Operating Hours:

           Packaging Machine per day                                                                                              9.7              19.4
           Autoclave per day                                                                                                     16                32
           Still per day                                                                                                         10                20
           Steam Generator per day                                                                                               16                32

8.    Process Steam Requirements per year in metric tons (@ 116 psi)
         Packaging Machine                                                                                                        53               106
         Still                                                                                                                   584             1,168
         Steam Generator                                                                                                       3,757             7,514
         Slip Steam                                                                                                              360               360
         Subtotal                                                                                                              4,754             9,148
Nerve Access, Inc.: Quality Research and Manufacture of Pharmaceuticals and Medical Products
8534 Thomas Charles Ln Suite A, Hickory Hills, IL 60457 – USA      Tel: 708 – 393 – 6383  Fax: 708 – 496 – 6466
Website: www.nerveaccess.com                                       Email: contact@nerveaccess.com
            Environmental Heating                                                                                               979           1,958

            Grand Total                                                                                                       2,553          11,106

INPUTS/OU T P U T S > > > > > > > > > > > > > > > > > > > > > > > > > > ( C o n t i n u e d )

For Rated Capacity                                                                                                4M Micro-Facility 8M Micro-Facility

9.    Coal Requirements per year in metric tons (if used)                                                                      540               970

10. Water Requirements per year in gallons/Still Feed and Cooling                                                           810,000         1,620,000
       Rinsing and Cleaning                                                                                                  81,000           162,000
       Steam Generator                                                                                                    1,014,000         2,028,000
       Total in Gallons                                                                                                   1,905,000         3,810,000
       Total in Metric Tons                                                                                                   7,200            14,300

              Still Out put                                                                                                 531,915         1,063,830

11. Power Requirements KWh

               Packaging Machine                                                                                            112,594           225,188

               Steam Generator                                                                                                7,347            14,694

               Still Pumps                                                                                                    6,725            13,450

               Subtotal                                                                                                     126,666           253,332

               HVAC and Miscellany                                                                                          109,500           219,000

               Grand Total                                                                                                  236,166           472,332

               Daily Operational Demand                                                                                         714             1,428

              Operational Peak Demand                                                                                            54              108
Nerve Access, Inc.: Quality Research and Manufacture of Pharmaceuticals and Medical Products
8534 Thomas Charles Ln Suite A, Hickory Hills, IL 60457 – USA      Tel: 708 – 393 – 6383  Fax: 708 – 496 – 6466
Website: www.nerveaccess.com                                       Email: contact@nerveaccess.com
T h e p r e c e d i n g n u m b e r s a r e e s t i m a t e s b a s e d o n a n a s s u m e d s t yl e a n d k i n d o f p a c k a g i n g . T h e s e f i g u r e s m a y v a r y
depending on the kind of instal lation that is installed. However, for estimating the needs and usage‟s these are
good guidelines.




Nerve Access, Inc.: Quality Research and Manufacture of Pharmaceuticals and Medical Products
8534 Thomas Charles Ln Suite A, Hickory Hills, IL 60457 – USA      Tel: 708 – 393 – 6383  Fax: 708 – 496 – 6466
Website: www.nerveaccess.com                                       Email: contact@nerveaccess.com
LVPS, Ltd. - - CHICAGO, ILLINOIS - USA
   GANTZ CHART FOR THE CONSTRUCTION OF A LVPS, Ltd. MICRO -MANUFACTURING FACILITY™

                                                                MONTH         1st 2nd 3rd 4th 5th 6th 7th 8th 9th 10th
-------------------------------------------------------------------------------------------------------------------------------
                            DESCRIPTION OF TASKS
 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

CONCLUDE PURCHASE AGREEMENT AND FINANCING

CONTRACT FOR LVPS MICRO-MANUFACTURING FACILITY™                                                                   XXX

SURVEY SITE/LOCATION FOR LVPS MICRO -MANUFACTURING FACILITY™                                                            XXX

REQUISITION MAJOR COMPONENTS                              OF EQUIPMENT                                                  XXX

DEVELOP FINITE ENGINEERING SPECIFICATIONS                                                                               XXXXXXX

CONSTRUCT LVPS MICRO-MANUFACTURING FACILITY™ IN USA                                                                     XXXXXXXXXXXXXXXXXXXXXXXXXXXXX

REQUISITION HVAC AND PROCESS EQUIPMENT                                                                                              XXX

REQUISITION PACKING EQUIPMENT                                                                                                             XXX

INTERVIEW OPERATING PERSONNEL                                                                                                                   XXX

SELECT OPERATING PERSONNEL                                                                                                                            XXXXXXX

RECEIVE MAJOR COMPONENTS                                                                                                                                XXXXX

REQUISITION OPERATING AND VALIDATION SUPPLIES                                                                                                            XXX

TRAIN OPERATING PERSONNEL AND VALIDATE IN THE USA                                                                                  XXXXXXXXXXXXXXXXX

DISASSEMBLE LVPS MICRO-MANUFACTURING FACILITY™

SHIP LVPS MICRO-MANUFACTURING FACILITY™ TO BUYERS LOCATION

RE-ASSEMBLE MICRO-MANUFACTURING FACILITY AT BUYER’S LOCATION

RE-VALIDATE LVPS MICRO-MANUFACTURING FACILITY TO US -FDA AND US-CGMPs

BEGIN PRODUCTION OF LVPs

DISTRIBUTE LVPs               TO CUSTOMERS

Nerve Access, Inc.: Quality Research and Manufacture of Pharmaceuticals and Medical Products
8534 Thomas Charles Ln Suite A, Hickory Hills, IL 60457 – USA      Tel: 708 – 393 – 6383  Fax: 708 – 496 – 6466
Website: www.nerveaccess.com                                       Email: contact@nerveaccess.com
FOR THE PRODUCTION OF I V SOLUTIONS

`11th 12th 13th 14th 15th 16th 17th 18th 19th 20th 21st 22nd 23rd 24th
-------------------------------------------------------------------------------------------------------------------------------




XXXXXXXXXXX




XX.


XXXX

XXXXXXX

XXXXXXXXXXXXXXXX

                      XXXXX

                                  XXXX

                                        XXXX

                                           XXXXX

                                              XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX

                                                  XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
Nerve Access, Inc.: Quality Research and Manufacture of Pharmaceuticals and Medical Products
8534 Thomas Charles Ln Suite A, Hickory Hills, IL 60457 – USA      Tel: 708 – 393 – 6383  Fax: 708 – 496 – 6466
Website: www.nerveaccess.com                                       Email: contact@nerveaccess.com

				
DOCUMENT INFO
Shared By:
Categories:
Tags:
Stats:
views:37
posted:8/3/2011
language:English
pages:29